Targeted Sequencing (TAR) Reports
===============================================

.. _tar-ini-config:

Djerba INI configuration
~~~~~~~~~~~~~~~~~~~~~~~~~

First, set up the working directory as outlined in :ref:`djerba-working-dir`.

Information is usually obtained either from one of two Data Sources: the Requisition (Req) system or Dimsum.

* :ref:`navigate-reqsys`
* :ref:`navigate-dimsum`

The following information must be populated into the .ini file:

.. list-table:: Fields to fill tar_input_params_helper section
	:widths: 20 20 20 20
	:header-rows: 1

	* 	- Parameter
		- Source
		- Description
		- Example
	*	- ``donor``
		- Dimsum, first link
		- LIMS ID comprising the study name and patient number
		- REVOLVE_0001
	* 	- ``project``
		- Dimsum, first link
		- Name of the project in provenance
		- REVTAR
	* 	- ``study``
		- Req system, ‚ÄúName of study (acronym)‚Äù under ‚ÄúSubmission‚Äù tab
		- Requisition system
		- Re-VOLVE
	*	- ``oncotree_code``
		- Req system, ‚ÄúOncoTree code‚Äù under ‚ÄúSubmission‚Äù tab
		- OncoTree code
		- HGSOC
	*	- ``cbio_id``
		- shesmu_
		- (When not known, same as project)
		- REVOLVE
	*	- ``patient_study_id``
		- Req system. ‚ÄúPatient study ID‚Äù under ‚ÄúSubmission‚Äù tab.
		- Patient study ID in requisition system. Refer to the ‚ÄúExternal Names‚Äù in MISO to find the ‚ÄúPatient Study ID‚Äù within the requisition system, eg. REVOLVE_001 -> REV-TAR-329.
		- REV-01-001
	*	- ``tumour_id``
		- Dimsum, Test, Tumour TS
		- ID of tumour sample
		- REV-01-001_Pl
	*	- ``normal_id``
		- Dimsum, Test, Normal TS
		- ID of blood sample
		- REV-01-001_BC
	*	- ``primary_cancer``
		- Req system, ‚ÄúPrimary cancer diagnosis‚Äù under ‚ÄúSubmission‚Äù tab
		- Name of primary cancer
		- High grade serous ovarian carcinoma
	*	- ``site_of_biopsy``
		- Req system
		- Site of biopsy/surgery (usually cfDNA)
		- cfDNA
	*	- ``sample_type``
		- Req system
		- Sample type  (usually cfDNA)
		- cfDNA
	*	- ``known_variants``
		- Req system
		- A known variant from previous genetic testing
		- TP53 p.(D158*)
	*	- ``requisition_approved``
		- Req system, ‚ÄòSubmission approved‚Äù date under ‚ÄúCase History‚Äù tab
		- Date of first requisition approval by Tissue Portal staff in yyyy-mm-dd format
		- 2023-10-31
	*	- ``requisition_id``
		- Req system, Top of the requisition after ‚ÄúID‚Äù
		- Name of the requisition
		- REVWGTS-P-861
	*	- ``assay``
		- Req system
		- The assay used (targeted sequencing assay, value is ‚ÄúTAR‚Äù)
		- TAR

.. list-table:: Fields to fill ``provenance_helper`` section
	:widths: 20 20 20 20
	:header-rows: 1
	
	* 	- ``sample_name_normal``
		- Dimsum - Full Depth Sequencings
		- Default value is None
		- REVOLVE_0001_01_LB01-02
	*	- ``sample_name_tumour``
		- Dimsum - Full Depth Sequencings
		- Default value is None
		- REVOLVE_0001_04_LB01-02
	*	- ``sample_name_aux``
		- Dimsum - Full Depth Sequencings
		- Default value is None
		- REVOLVE_0001_04_LB01-01
	*	- ``sample_name_normal``
		- Dimsum - Full Depth Sequencings
		- 
		- REVOLVE_0001_01_LB01-02

.. list-table:: Fields to fill ``tar.status`` section
	:widths: 20 20 20 20
	:header-rows: 1

	*	- ``copy_number_ctdna_detected``
		- Upon review of ichorCNA plot
		- Default value is False
		- False/True
	*	- ``small_mutation_ctdna_detected``
		- Upon review of the reported SNVs
		- Default value is False
		- False/True

.. _shesmu: https://bitbucket.oicr.on.ca/projects/GSI/repos/analysis-config/browse/shesmu/common/tgl_project.jsonconfig


Example of a completed Djerba INI file
***************************************

Spaces are acceptable in the parameter value and on either side of the = sign::

	[core]

	[tar_input_params_helper]
	donor=REVOLVE_0001
	project=REVTAR
	study=Re-VOLVE
	oncotree_code=HGSOC
	cbio_id=REVOLVE
	patient_study_id=REV-01-001
	tumour_id=REV-01-001_Pl
	normal_id=REV-01-001_BC
	primary_cancer=High grade serous ovarian carcinoma
	site_of_biopsy=cfDNA
	sample_type = cfDNA
	known_variants=<em>TP53</em> (p.D148*)
	requisition_approved=2023-05-09
	requisition_id = REVWGTS-P-861
	assay=TAR

	[provenance_helper]
	sample_name_normal = REVOLVE_0001_01_LB01-02
	sample_name_tumour = REVOLVE_0001_04_LB01-02
	sample_name_aux = REVOLVE_0001_04_LB01-01

	[report_title]

	[patient_info]

	[case_overview]

	[gene_information_merger]

	[treatment_options_merger]

	[summary]

	[tar.sample]

	[tar.snv_indel]

	[tar.swgs]

	[tar.status]
	copy_number_ctdna_detected = False
	small_mutation_ctdna_detected = False

	[supplement.body]

Interim Report Generation
~~~~~~~~~~~~~~~~~~~~~~~~~~

#. Login and setup the analysis environment on a Univa compute node, as described in step 1.
#. Run djerba.py in report mode to generate an HTML report. (See below for examples.)
#. Output filename is of the form ``${TUMOUR_ID}-v{VERSION_NUMBER}.html`` in the report directory, where $TUMOUR_ID is the tumour ID from Dimsum.
#. Run the script using the INI file completed in :ref:`tar-ini-config` and the ‚Äòreport‚Äô subdirectory created in :ref:`djerba-working-dir` for intermediate output. Example::

	$ djerba.py report -i config.ini -o report/ 

#. Proceed to review and interpretation of the interim HTML output.

Interpreting the TAR Report
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Most results are reviewed within the interim report. Results reviewed by other means are explicitly mentioned in the text.

#. Review and confirm accuracy of non-PHI fields on interim report relative to current requisition in requisition portal in the case overview section.
#. Information regarding the tumour will be listed in the ‚ÄúSample Information‚Äù section:
#. Review whizbam links for variants:

	* All variant calls must be viewed to gauge whether they are confident and thus reportable or an artifact and thus must be removed.
	* In general, if there are non-variant supporting reads in the normal, the variant is more likely to be an artifact. 
	* Examples: :ref:`tar-whizbam-examples`

.. _review the ichorCNA plot:

#. Examine the copy number solution in ``report/$(sample_name_aux)_genomeWide.pdf``. If the tumour fraction is less than 10%, confirm that the plot is centered at 0. If the tumour fraction is greater than 10%, confirm that the plot is centered at 0 and determine if the high tumour fraction is being driven by potentially artifact chromosomal regions. The regions that correspond to recurrent artifacts commonly found in healthy controls (i.e. likely false positives) are: 1p, 10q, 17, 19, and 22.

	* Examples: :ref:`tar-ichor-examples`
	* If it is determined that the high purity is likely driven by potentially artifact chromosomal regions, change the estimated tumour fraction to <10%. Copy number variants must be removed.

#. After reviewing both the copy number variants and the small mutations, the parameters in ``[tar.status]`` in the ``config.ini`` may need to be adjusted. Both ``copy_number_ctdna_detected`` and ``small_mutation_ctdna_detected`` automatically default to False.

	.. image:: images/tar-status1.png

	After reviewing the SNVs and purity/CNVs, adjust the parameters as follows:

		* ``copy_number_ctdna_detected = True`` if the purity is ‚â• 10%
		* ``small_mutation_ctdna_detected = True`` if there are high confidence SNVs present 

	Once done, re-generate the report to ensure changes to ``[tar.status]`` are rendered correctly::
	
		$ djerba.py report -i config.ini -o report/

	For example, for a report with ``copy_number_ctdna_detected = True`` and ``small_mutation_ctdna_detected = False``, the output will be:

	.. image:: images/tar-status2.png

#. Once the variants to remove have been identified, remove them from ``djerba_report.json``. :ref:`json-tips`

	.. note:: 
			For all follow-up cases, ensure that the status is consistent with the previous submission. If the case is positive ‚Äî either due to a tumor fraction >10% or the presence of a reported SNV ‚Äî be sure to double-check the original ichorCNA plot and confirm the variants reported in the initial submission.

			It is not uncommon for the follow-up report to show new variants or higher tumor fraction; this can occur if the original sample was below our limit of detection. In such cases, review the old data in IGV to see if any supporting reads were present, and examine the ichorCNA plot for amplifications that may align with the current findings. 

#. If prior knowledge of previous sequencing results or biomarkers is known, review the relevant sections of the report to confirm and note abnormalities.
	
	* If any discrepancy is noted, the sample should be marked as failed in Dimsum according to the QM-036 Quality Control Approval Procedure SOP and a :ref:`tar-failed-report` should be generated.

	.. list-table:: Possible abnormalities
		:widths: 30 30 40
		:header-rows: 1

		*	- Abnormality
			- Potential Cause
			- Action
		* 	- Lack of expected alteration, or presence of a mutation in a cancer type where the mutation is expected or not expected
			- * Lack of coverage for the expected mutation
			  * Sample swap
			  * Mutation is filtered
			- * Verify coverage for the region by inspecting the bam file in Whizbam
			  * Check for sample swaps
			  * Confirm mutation was not removed by pipeline by reviewing the MuTect2 VCF file
		*	- Prior sequencing results are not confirmed
			- * Low coverage for the expected mutation
			  * Sample swap
			  * Mutation is filtered
			- * Verify coverage for the region by inspecting the bam file in Whizbam
			  * Check for sample swaps
			  * Confirm mutation was not removed by pipeline by reviewing the MuTect2 VCF file


#. Review the Small Mutations (SNVs/INDELs) section of the report. SNVs and INDELs are reported according to the following filtering criteria:

	.. list-table:: SNV/InDels filter criteria
		:widths: 50 50
		:header-rows: 1

		* 	- Filter
			- Threshold
		*	- Variant Allele Frequency (VAF)
		 	- ‚â• 1%
		*	- Supporting Alternate Reads
			- ‚â• 3 reads
		*	- OncoKB
			- * All level 1-4, R variants which pass the above criteria
			  * All ‚ÄúOncogenic‚Äù, ‚ÄúLikely Oncogenic‚Äù and ‚ÄúPredicted Oncogenic‚Äù alterations which pass the above criteria

	* Review all actionable and/or oncogenic mutations using Whizbam links for alignment artifacts. Whizbam links can be navigated to by clicking the link in the rightmost column in the ``data_mutations_extended_oncogenic.txt`` file in the patient's ``report`` directory.  Alterations which are deemed artifacts are to be removed from the JSON file and recorded on the relevant JIRA ticket.
	* Dinucleotide substitutions which are represented as two individual mutations are to be merged. Merged variants should be recorded in a new file named ``data_mutations_merged.txt``. Copy both original individual annotations to this file, along with a third record of the final merged variant. To perform this merge, please follow this step-by-step procedure in the `Merging and Annotating Mutations Representing the Same Eventüîí`_ document on CGI:How-to wiki page.

.. _Merging and Annotating Mutations Representing the Same Eventüîí : https://wiki.oicr.on.ca/spaces/GSI/pages/293634774/Merging+and+Annotating+Mutations+Representing+the+Same+Event

#. Generate an interpretation statement based on the findings from above and record it in a TXT file named ``results_summary.txt``

	* For samples flagged as follow-up, include an additional statement to comment on the shared and/or exclusive variants relative to prior sequencing results. 
	* For an example summary, please refer to our wiki page on writing a `genome interpretive statementüîí`_.
	* Use the following template as an example:

	.. list-table:: Writing a TAR interpretation statement
		:widths: 50 50
		:header-rows: 1

		*	- Analysis Subsection
			- Example statement
		*	- Comparison to prior sequencing results (for follow-up samples only)
			- Comment on the number of shared and exclusive mutations relative to prior sequencing results. When newly reported variants are discovered, include OncoKB recommendations for any new indications:
			  ‚ÄúRelative to prior sequencing of [current sample X], [prior sample Y] shares 3 common variants and one variant is exclusive to, and has 1 additional oncogenic variant in gene A
		* 	- SNV/Indel 
			- ‚ÄúMutations analysis uncovered loss of function mutations in xxx genes that suggest xxx.‚Äù
		*	- Copy Number
			- ‚ÄúCopy Number analysis uncovered an amplification in xxx genes that suggest xxx.‚Äù
		*	- OncoKB treatment recommendations
			- Statements are taken from oncoKB:
			  ‚ÄúAlteration xxx is a Level 1 mutation which the following treatment recommendations according to oncoKB‚Äù

.. _genome interpretive statementüîí : https://wiki.oicr.on.ca/display/GSI/Write+a+Genome+Interpretive+Statement

Updating QCs
~~~~~~~~~~~~~~~~~~~

The only QC for CGI to complete is to `review the ichorCNA plot`_, which was done above.

Sign off on the "Informatics Review" in Dimsum according to the QM-036. Quality Control Approval Procedure.


Draft Report
~~~~~~~~~~~~~~~~~~~~~~~~

Regenerate the PDF report with the interpretation changes and summary text:

	* Update the genomic summary text in the report JSON document as follows (note that input and output for the ``update_summary.py`` script may be the same file)::

		$ djerba.py update -s report/results_summary.txt -j report/report.json -o report/ -p

Continue to :ref:`Review the Draft Report` ‚û°Ô∏è
**********************************************



Example Djerba TAR session
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

The following is an example sequence of commands used to generate a clinical report with Djerba. It is intended as a guide to CGI staff for report generation. The commands are for illustration only, not a fixed script to be followed. The start of each command is prefixed with $, and comments are prefixed with #::

	$ ssh ugehn.hpc
	$ sudo -u svc.cgiprod -i
	$ qrsh -P gsi -l h_vmem=16G
	$ module load djerba
	$ cd WORK_DIR

	# make a folder with the donor name, ex. REVOLVE_0001
	$ mkdir REVOLVE_0001
	$ cd REVOLVE_0001

	# make a folder with the report directory, i.e. report/
	$ mkdir report

	# create a config.ini file
	$ djerba.py setup --assay ASSAY --ini {WORK_DIR}/config.ini --compact ‚Äìp ../../../CHARM2PLAS_project.ini
	$ vim  {WORK_DIR}/config.ini

	# run djerba.py to generate a report
	$ djerba.py report -i config.ini -o report/

	# review the HTML
	# review whizbam links in data_mutations_extended_oncogenic.txt 
	# remove any false calls in djerba_report.json (use json.tool to make it easier)
	$ cat djerba_report.json | python3 -m json.tool > report/djerba_report_machine.pretty.json
	$ vim djerba_report_machine.pretty.json

	# edit results_summary.txt to write the genomic summary 
	$ vim report/results_summary.txt

	# update the ctDNA plugin status from "Not Detected‚Äù to ‚ÄúDetected‚Äù if needed
	# update the genomic summary
	$ djerba.py update -s report/results_summary.txt -j report/report.json -o report/ -p


+----------------+----------------------+
| **Change Log** | `Github commit log`_ |
+----------------+----------------------+

.. _Github commit log : https://github.com/oicr-gsi/oicr-gsi/commits/main/source/data-review-reporting/tar-report.rst

